Literature DB >> 9524766

Plasminogen/plasminogen activator and growth factor activation.

D B Rifkin1, P E Gleizes, J Harpel, I Nunes, J Munger, R Mazzieri, I Noguera.   

Abstract

The plasminogen/plasminogen activator system is widely used in extracellular proteolysis. In this review the involvement of this system in tumour invasion, cell migration, growth factor presentation and inhibition of angiogenesis are discussed.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9524766     DOI： 10.1002/9780470515457.ch7

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN： 0300-5208


  7 in total

1.  Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures.

Authors:  Tai-Lan Tuan; Huayang Wu; Eunice Y Huang; Sheree S N Chong; Walter Laug; Diana Messadi; Paul Kelly; Anh Le
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 2.  Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing.

Authors:  Aman Opneja; Sargam Kapoor; Evi X Stavrou
Journal:  Thromb Res       Date:  2019-05-02       Impact factor: 3.944

3.  Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator.

Authors:  Alexander de Giorgio-Miller; Steve Bottoms; Geoffrey Laurent; Peter Carmeliet; Sarah Herrick
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

4.  Prospective and randomised evaluation of the protease-modulating effect of oxidised regenerated cellulose/collagen matrix treatment in pressure sore ulcers.

Authors:  Oliver Kloeters; Frank Unglaub; Erik de Laat; Marjolijn van Abeelen; Dietmar Ulrich
Journal:  Int Wound J       Date:  2015-05-23       Impact factor: 3.315

5.  Effect of oxidised regenerated cellulose/collagen matrix on proteases in wound exudate of patients with chronic venous ulceration.

Authors:  Ralf Smeets; Dietmar Ulrich; Frank Unglaub; Michael Wöltje; Norbert Pallua
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

Review 6.  TGF-beta: how tolerant can it be?

Authors:  Sharon M Wahl; Wanjun Chen
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  Inhibitory role of plasminogen activator inhibitor-1 in invasion and proliferation of HLE hepatocellular carcinoma cells.

Authors:  Y Morita; Y Hayashi; T Kanamaru; T Itoh; S Suzuki; M Yamamoto; Y Kuroda; H Itoh
Journal:  Jpn J Cancer Res       Date:  1999-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.